Qin, Chuan
Tian, Dai-Shi http://orcid.org/0000-0002-7627-0811
Zhou, Luo-Qi
Shang, Ke
Huang, Liang http://orcid.org/0000-0002-8370-3232
Dong, Ming-Hao
You, Yun-Fan
Xiao, Jun
Xiong, Ying
Wang, Wen http://orcid.org/0000-0003-3215-3020
Pang, Hao
Guo, Jing-Jing
Cai, Song-Bai
Wang, Di
Li, Chun-Rui
Zhang, Min
Bu, Bi-Tao
Wang, Wei
Funding for this research was provided by:
Nanjing IASO Biotherapeutics Ltd
Article History
Received: 1 October 2022
Revised: 9 November 2022
Accepted: 13 November 2022
First Online: 4 January 2023
Competing interests
: Wen W. held interests in patent applications related to the CT103A. Wen W., S.-B.C., J.-J.G., and H.P. are employees of Nanjing IASO Therapeutics Ltd. and held interests in the company. All other authors declared no competing interests.